VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,370,575 | +64.4% | 106,161 | +87.5% | 0.06% | +55.3% |
Q2 2023 | $1,442,086 | -49.7% | 56,619 | -56.0% | 0.04% | -51.9% |
Q1 2023 | $2,867,936 | +24.9% | 128,607 | +32.9% | 0.08% | +21.5% |
Q4 2022 | $2,296,400 | +127.8% | 96,772 | +59.3% | 0.06% | +85.7% |
Q3 2022 | $1,008,000 | +16.0% | 60,752 | +242.1% | 0.04% | -62.0% |
Q4 2020 | $869,000 | +122.3% | 17,760 | +47.5% | 0.09% | +268.0% |
Q3 2020 | $391,000 | +83.6% | 12,039 | +35.6% | 0.02% | +38.9% |
Q3 2019 | $213,000 | -68.4% | 8,878 | -62.4% | 0.02% | -70.5% |
Q2 2019 | $673,000 | +307.9% | 23,607 | +79.8% | 0.06% | +510.0% |
Q4 2018 | $165,000 | +10.7% | 13,132 | -15.9% | 0.01% | -9.1% |
Q3 2018 | $149,000 | -32.3% | 15,621 | -37.6% | 0.01% | -80.0% |
Q3 2017 | $220,000 | -52.9% | 25,030 | -50.8% | 0.06% | -8.3% |
Q1 2017 | $467,000 | +190.1% | 50,865 | +145.0% | 0.06% | +140.0% |
Q4 2016 | $161,000 | – | 20,765 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |